PrecisionPhage is a biotech business that specializes on bacteriophage technologies.
PrecisionPhage has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in November 2024.
PrecisionPhage's investors include Nordic Science Investments, Business Finland, Unifund.
PrecisionPhage is headquartered in Jyväskylä, Finland.
PrecisionPhage is a biotech business that specializes on bacteriophage technologies.
PrecisionPhage is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PrecisionPhage — Funding & Investors." VCBacked, November 12, 2024, https://www.vcbacked.co/company/precisionphage. Accessed October 31, 2026.
VCBacked. (2024). PrecisionPhage — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/precisionphage
{{cite web |title=PrecisionPhage — Funding & Investors |url=https://www.vcbacked.co/company/precisionphage |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated